p73 competes with p53 and attenuates its response in a human ovarian cancer cell line

Por Vikhanskaya, Faina, D’Incalci, Maurizio, Broggini, Massimo
Publicado em 2000

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment

Por Galmarini, Carlos M., D’Incalci, Maurizio, Allavena, Paola
Publicado em 2014

New activities for the anti-tumor agent trabectedin: taking two birds with one stone

Por D'Incalci, Maurizio, Frapolli, Roberta, Germano, Giovanni, Allavena, Paola
Publicado em 2013

Is PDGFR an important target for E-3810?

Por Damia, Giovanna, Colella, Gennaro, Camboni, Gabriella, D'Incalci, Maurizio
Publicado em 2012

Trabectedin: A drug from the sea that strikes tumor-associated macrophages

Por Allavena, Paola, Germano, Giovanni, Belgiovine, Cristina, D’Incalci, Maurizio, Mantovani, Alberto
Publicado em 2013

Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743

Por Minuzzo, Mario, Marchini, Sergio, Broggini, Massimo, Faircloth, Glynn, D'Incalci, Maurizio, Mantovani, Roberto
Publicado em 2000

Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation

Por Damia, Giovanna, Filiberti, Laura, Vikhanskaya, Faina, Carrassa, Laura, Taya, Yoichi, D'incalci, Maurizio, Broggini, Massimo
Publicado em 2001

Driving p53 Response to Bax Activation Greatly Enhances Sensitivity to Taxol by Inducing Massive Apoptosis

Por De Feudis, Paola, Vignati, Sara, Rossi, Cosmo, Mincioni, Tatiana, Giavazzi, Raffaella, D'Incalci, Maurizio, Broggini, Massimo
Publicado em 2000

Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging

Por Morosi, Lavinia, Spinelli, Pietro, Zucchetti, Massimo, Pretto, Francesca, Carrà, Andrea, D’Incalci, Maurizio, Giavazzi, Raffaella, Davoli, Enrico
Publicado em 2013

Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profiles

Por Calura, Enrica, Martini, Paolo, Sales, Gabriele, Beltrame, Luca, Chiorino, Giovanna, D’Incalci, Maurizio, Marchini, Sergio, Romualdi, Chiara
Publicado em 2014

Snail levels control the migration mechanism of mesenchymal tumor cells

Por BELGIOVINE, CRISTINA, CHIESA, GIULIO, CHIODI, ILARIA, FRAPOLLI, ROBERTA, BONEZZI, KATIUSCIA, TARABOLETTI, GIULIA, D'INCALCI, MAURIZIO, MONDELLO, CHIARA
Publicado no Oncol Lett (2016)

The Effects of Vandetanib on Paclitaxel Tumor Distribution and Antitumor Activity in a Xenograft Model of Human Ovarian Carcinoma

Por Cesca, Marta, Frapolli, Roberta, Berndt, Alexander, Scarlato, Valentina, Richter, Petra, Kosmehl, Hartwig, D'Incalci, Maurizio, Ryan, Anderson J, Giavazzi, Raffaella
Publicado em 2009

Towards a Model-Based Dose Recommendation for Doxorubicin in Children

Por Völler, Swantje, Hempel, Georg, Würthwein, Gudrun, Boddy, Alan V., Krischke, Miriam, André, Nicolas, D’Incalci, Maurizio, Bisogno, Gianni, Boos, Joachim
Publicado no Clin Pharmacokinet (2016)

Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway

Por Rizzo, Angela, Salvati, Erica, Porru, Manuela, D’Angelo, Carmen, Stevens, Malcolm F., D’Incalci, Maurizio, Leonetti, Carlo, Gilson, Eric, Zupi, Gabriella, Biroccio, Annamaria
Publicado em 2009

Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a “European Pediatric Oncology Off-patents Medicines Consortium” trial

Por Krischke, Miriam, Hempel, Georg, Völler, Swantje, André, Nicolas, D’Incalci, Maurizio, Bisogno, Gianni, Köpcke, Wolfgang, Borowski, Matthias, Herold, Ralf, Boddy, Alan V., Boos, Joachim
Publicado no Cancer Chemother Pharmacol (2016)

Reduced Expression of the ROCK Inhibitor Rnd3 Is Associated with Increased Invasiveness and Metastatic Potential in Mesenchymal Tumor Cells

Por Belgiovine, Cristina, Frapolli, Roberta, Bonezzi, Katiuscia, Chiodi, Ilaria, Favero, Francesco, Mello-Grand, Maurizia, Dei Tos, Angelo P., Giulotto, Elena, Taraboletti, Giulia, D'Incalci, Maurizio, Mondello, Chiara
Publicado em 2010

ANTICANCER ACTIVITY OF PYRIPLATIN, A MONOFUNCTIONAL CATIONIC PLATINUM(II) COMPOUND, IN HUMAN CANCER CELLS

Por Lovejoy, Katherine S., Serova, Maria, Bieche, Ivan, Emami, Shahin, D'Incalci, Maurizio, Broggini, Massimo, Erba, Eugenio, Gespach, Christian, Cvitkovic, Esteban, Faivre, Sandrine, Raymond, Eric, Lippard, Stephen J.
Publicado em 2011

IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer

Por Mosig, Rebecca A, Lobl, Mollie, Senturk, Emir, Shah, Hardik, Cohen, Samantha, Chudin, Eugene, Fruscio, Robert, Marchini, Sergio, D'Incalci, Maurizio, Sachidanandam, Ravi, Dottino, Peter, Martignetti, John A
Publicado em 2012

A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma

Por Uboldi, Sarah, Calura, Enrica, Beltrame, Luca, Fuso Nerini, Ilaria, Marchini, Sergio, Cavalieri, Duccio, Erba, Eugenio, Chiorino, Giovanna, Ostano, Paola, D'Angelo, Daniela, D'Incalci, Maurizio, Romualdi, Chiara
Publicado em 2012

A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin

Por Grosso, Federica, D’Incalci, Maurizio, Cartoafa, Mirela, Nieto, Antonio, Fernández-Teruel, Carlos, Alfaro, Vicente, Lardelli, Pilar, Roy, Elena, Gómez, Javier, Kahatt, Carmen, Soto-Matos, Arturo, Judson, Ian
Publicado em 2012